Penumbra
PEN
#1771
Rank
HK$71.64 B
Marketcap
HK$1,867
Share price
-0.08%
Change (1 day)
-8.12%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Earnings for Penumbra (PEN)

Earnings in 2024 (TTM): -HK$6.38 Million

According to Penumbra's latest financial reports the company's current earnings are HK$1.16 Billion. In 2023 the company made an earning of HK$0.64 Billion, an increase over its 2022 earnings that were of HK$47.23 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Penumbra from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$6.38 Million-100.98%
2023 HK$0.64 B1272.57%
2022 HK$47.23 M-181.08%
2021 -HK$58.26 Million-80.74%
2020 -HK$0.31 Billion-181.97%
2019 HK$0.36 B58.45%
2018 HK$0.23 B2473.65%
2017 HK$9.04 M-186.3%
2016 -HK$10.49 Million-132.3%
2015 HK$32.45 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$0.42 Billion 7,901.96%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.37 B-26,724.13%๐Ÿ‡บ๐Ÿ‡ธ USA